SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-18-002120
Filing Date
2018-07-19
Accepted
2018-07-18 21:14:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d07422010_07182018.htm SC 13D 241310
2 JOINT FILING AGREEMENT ex991to13d07422010_07182018.htm EX-99.1 12335
  Complete submission text file 0000921895-18-002120.txt   255339
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice
Assistant Director 7

Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Subject) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90180 | Film No.: 18959433
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1